The pharmaceuticals industry produces both prescription and over-the-counter drugs, as well as brand-name and generic medicines for humans and animals. Manufacturers produce active ingredients, including chemical preparations and biological-pharmaceutical products, to serve a range of treatments for diabetes; mental health; respiratory problems; pain suppression; autoimmune disease; skin conditions; high cholesterol and many more. Demand comes from wholesaling, as well as consumer sales through supermarkets, pharmacies, and hospitals. Typical machinery and equipment (M&E) includes: container fillers; conveyors; mixers; reactors; kettles; unscramblers; sealers; cappers; wrappers; labelers; lab equipment; packaging machinery; and weigh scales.
This pharmaceuticals industry is comprised of approximately 4,200 companies in the U.S., with annual revenue totaling $243 billion. Market-share for brand-name pharmaceuticals is moderate, with the four largest brands (Johnson & Johnson, Roche, Pfizer, Novartis) accounting for 29% of industry revenue. The top three generic manufacturers (Teva, Sandoz, Actavis) account for just 6%. Pharmaceutical imports and exports are both high, with growth expected through 2022 as emerging markets in China, Brazil and India fuel demand. While generic drug companies haven’t needed the same level of R&D investment as brand-name firms, the playing field is leveling as the FDA adds more regulatory framework for biosimilar drug development.